Lucid Diagnostics Inc

NAS:LUCD (USA)  
$ 0.74 -0.0457 (-5.74%) 10:08 PM EST
At Loss
Market Cap:
$ 35.70M
Enterprise V:
$ 53.41M
Volume:
169.28K
Avg Vol (2M):
203.08K
Volume:
169.28K
At Loss
Avg Vol (2M):
203.08K

Business Description

Lucid Diagnostics Inc
NAICS : 325413 SIC : 3845
ISIN : US54948X1090
Description
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
Name Current Vs Industry Vs History
Cash-To-Debt 1.24
Equity-to-Asset -0.09
Debt-to-Equity -6.6
Debt-to-EBITDA -0.31
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -13.51
Distress
Grey
Safe
Beneish M-Score 0.81
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 10.04
9-Day RSI 18.38
14-Day RSI 22.75
6-1 Month Momentum % -14.17
12-1 Month Momentum % -28.76

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.75
Quick Ratio 0.74
Cash Ratio 0.64
Days Inventory 8.34
Days Sales Outstanding 4.36
Days Payable 54.44

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -4.6
Shareholder Yield % -33.43